|
1
|
Gene transfer in humans using a conditionally replicating lentiviral vector.
|
Proc Natl Acad Sci U S A
|
2006
|
4.23
|
|
2
|
Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector.
|
Hum Gene Ther
|
2005
|
1.30
|
|
3
|
Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha.
|
J Virol
|
2008
|
1.28
|
|
4
|
Development of a low bias method for characterizing viral populations using next generation sequencing technology.
|
PLoS One
|
2010
|
1.25
|
|
5
|
The CXCR4-tropic human immunodeficiency virus envelope promotes more-efficient gene delivery to resting CD4+ T cells than the vesicular stomatitis virus glycoprotein G envelope.
|
J Virol
|
2009
|
1.20
|
|
6
|
Lentiviral vectors in clinical trials: Current status.
|
Curr Opin Mol Ther
|
2009
|
1.14
|
|
7
|
Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infection.
|
PLoS One
|
2010
|
0.99
|
|
8
|
Patient monitoring and follow-up in lentiviral clinical trials.
|
J Gene Med
|
2013
|
0.86
|
|
9
|
Electroporation-enhanced delivery of nucleic acid vaccines.
|
Expert Rev Vaccines
|
2014
|
0.81
|
|
10
|
Potent inhibition of simian immunodeficiency virus (SIV) replication by an SIV-based lentiviral vector expressing antisense Env.
|
Hum Gene Ther
|
2007
|
0.75
|